five

Examining the Influence of COVID-19 Infection and Pandemic Restrictions on the Risk of Corneal Transplant Rejection or Failure: A Multicenter Study

收藏
DataCite Commons2023-10-11 更新2024-08-18 收录
下载链接:
https://tandf.figshare.com/articles/dataset/Examining_the_Influence_of_COVID-19_Infection_and_Pandemic_Restrictions_on_the_Risk_of_Corneal_Transplant_Rejection_or_Failure_A_Multicenter_Study/23653713/1
下载链接
链接失效反馈
官方服务:
资源简介:
The purpose of this study was to evaluate two aims. The first was whether patients with a history of keratoplasty who developed COVID-19 were at a higher risk of corneal graft rejection or failure. The second was examining whether patients who underwent a new keratoplasty during the first 2 years of the pandemic from 2020–2022 were at a higher risk of the same outcomes compared to those undergoing keratoplasty from 2017–2019 before the pandemic. A multicenter research network, TriNetX, was used to query for keratoplasty patients with or without a COVID-19 between January 2020 and July 2022. Additionally, the database was also queried to identify new keratoplasties performed from January 2020-July 2022 and compare it to keratoplasties performed during a similar pre-pandemic interval between 2017–2019. 1:1 Propensity Score Matching was utilized to adjust for confounders. Graft complication of either a rejection or failure was assessed within 120 day follow-up using the Cox proportional hazard model and survival analysis. A total of 21,991 patients with any keratoplasty history were identified from January 2020-July 2022, of which 8.8% were diagnosed with COVID-19. Matching revealed two balanced cohorts of 1,927 patients where no significant difference in risk of corneal graft rejection or failure among groups ((aHR [95% CI] = 0.76 [0.43,1.34]; <i>p</i> = .244)). Comparing first-time keratoplasties performed in a pandemic period of January 2020-July 2022 to a corresponding pre-pandemic interval from 2017–2019 also similarly revealed no differences in graft rejection or failure in matched analysis (aHR = 0.937[0.75, 1.17], <i>p</i> = .339). This study found no significant increase in the risk of graft rejection or failure in patients with a prior keratoplasty history following COVID-19 diagnosis nor in any patients who had a new keratoplasty done during 2020–2022 when compared to a similar pre-pandemic interval.
提供机构:
Taylor & Francis
创建时间:
2023-07-10
二维码
社区交流群
二维码
科研交流群
商业服务